Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy W Batenburg

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 30, 2008
Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskirenWendy W Batenburg, Ah Jan Danser
Clinical Science (London, England : 1979)|April 13, 2012
(Pro)renin and its receptors: pathophysiological implicationsWendy W Batenburg, A H Jan Danser
European Journal of Pharmacology|April 18, 2008
The (pro)renin receptor: a new addition to the renin-angiotensin system?Wendy W Batenburg, A H Jan Danser
Journal of Hypertension|June 14, 2008
Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heartAnton H van den Meiracker, Wendy W Batenburg
Molecular and Cellular Endocrinology|October 9, 2008
Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis?Mieke van den Heuvel, Wendy W Batenburg, A H Jan Danser
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 30, 2007
Prorenin and the (pro)renin receptor--an updateA H Jan Danser, Wendy W Batenburg, Joep H M van Esch
Vascular Pharmacology|March 29, 2005
Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s)Wendy W Batenburg, Beril Tom, Martin P Schuijt, et al.
Journal of Hypertension|September 14, 2004
L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries?Wendy W Batenburg, René de Vries, Pramod R Saxena, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 7, 2008
Prorenin anno 2008A H Jan Danser, Wendy W Batenburg, Joep H M van Esch, et al.
Pharmacology & Therapeutics|January 30, 2007
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?A H Jan Danser, Wendy W Batenburg, Anton H van den Meiracker, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 30, 2008
Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskirenWendy W Batenburg, Ah Jan Danser
Clinical Science (London, England : 1979)|April 13, 2012
(Pro)renin and its receptors: pathophysiological implicationsWendy W Batenburg, A H Jan Danser
European Journal of Pharmacology|April 18, 2008
The (pro)renin receptor: a new addition to the renin-angiotensin system?Wendy W Batenburg, A H Jan Danser
Journal of Hypertension|June 14, 2008
Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heartAnton H van den Meiracker, Wendy W Batenburg
Molecular and Cellular Endocrinology|October 9, 2008
Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis?Mieke van den Heuvel, Wendy W Batenburg, A H Jan Danser
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 30, 2007
Prorenin and the (pro)renin receptor--an updateA H Jan Danser, Wendy W Batenburg, Joep H M van Esch
Vascular Pharmacology|March 29, 2005
Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s)Wendy W Batenburg, Beril Tom, Martin P Schuijt, et al.
Journal of Hypertension|September 14, 2004
L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries?Wendy W Batenburg, René de Vries, Pramod R Saxena, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 7, 2008
Prorenin anno 2008A H Jan Danser, Wendy W Batenburg, Joep H M van Esch, et al.
Pharmacology & Therapeutics|January 30, 2007
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?A H Jan Danser, Wendy W Batenburg, Anton H van den Meiracker, et al.
Pageof 4